1. Home
  2. LSAK vs PACB Comparison

LSAK vs PACB Comparison

Compare LSAK & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSAK
  • PACB
  • Stock Information
  • Founded
  • LSAK 1997
  • PACB 2000
  • Country
  • LSAK South Africa
  • PACB United States
  • Employees
  • LSAK N/A
  • PACB N/A
  • Industry
  • LSAK Investment Bankers/Brokers/Service
  • PACB Biotechnology: Laboratory Analytical Instruments
  • Sector
  • LSAK Finance
  • PACB Industrials
  • Exchange
  • LSAK Nasdaq
  • PACB Nasdaq
  • Market Cap
  • LSAK 344.5M
  • PACB 364.2M
  • IPO Year
  • LSAK N/A
  • PACB 2010
  • Fundamental
  • Price
  • LSAK $4.43
  • PACB $1.24
  • Analyst Decision
  • LSAK
  • PACB Buy
  • Analyst Count
  • LSAK 0
  • PACB 9
  • Target Price
  • LSAK N/A
  • PACB $2.06
  • AVG Volume (30 Days)
  • LSAK 28.4K
  • PACB 9.3M
  • Earning Date
  • LSAK 05-07-2025
  • PACB 08-06-2025
  • Dividend Yield
  • LSAK N/A
  • PACB N/A
  • EPS Growth
  • LSAK N/A
  • PACB N/A
  • EPS
  • LSAK N/A
  • PACB N/A
  • Revenue
  • LSAK $574,080,000.00
  • PACB $152,357,000.00
  • Revenue This Year
  • LSAK $1.06
  • PACB $3.33
  • Revenue Next Year
  • LSAK $13.32
  • PACB $18.52
  • P/E Ratio
  • LSAK N/A
  • PACB N/A
  • Revenue Growth
  • LSAK 4.13
  • PACB N/A
  • 52 Week Low
  • LSAK $3.39
  • PACB $0.85
  • 52 Week High
  • LSAK $5.60
  • PACB $2.72
  • Technical
  • Relative Strength Index (RSI)
  • LSAK 59.14
  • PACB 56.77
  • Support Level
  • LSAK $3.85
  • PACB $1.14
  • Resistance Level
  • LSAK $4.24
  • PACB $1.40
  • Average True Range (ATR)
  • LSAK 0.24
  • PACB 0.10
  • MACD
  • LSAK 0.03
  • PACB 0.01
  • Stochastic Oscillator
  • LSAK 74.42
  • PACB 56.32

About LSAK Lesaka Technologies Inc.

Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates two reportable segments: Merchant and Consumer. The company operates mainly within South Africa. The Merchant segment that derives majority revenue includes activities related to the provision of goods and services provided to corporate and other juristic entities. It earns fees from processing activities performed for its customers and revenue generated from the distribution of prepaid airtime. The Consumer segment includes activities related to the provision of financial services to customers, including bank accounts, loans, and insurance products. The firm charges monthly administration fees for all bank accounts.

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

Share on Social Networks: